Targeting B cells, plasma cells may aid hidradenitis suppurativa treatment
Patients with hidradenitis suppurativa saw improvement with fostamatinib treatment, showing that targeting B cells and plasma cells could be an upcoming strategy in treating the disease, according to a study.“The pathogenesis of HS is associated with activation of the Th17 immune axis as witness in the success of Th17 antagonists in HS; however, there is a strong presence of multiple other
Source: healio.com